Board approves Q1 FY27 results, re-appoints MD
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Board meeting on August 11, 2026 approved unaudited Q1 FY27 results (quarter ended June 30, 2026). Statutory auditors Sampat and Mehta LLP issued a clean limited review report with no qualifications. EPS rose to Rs. 0.26 from Rs. 0.15 in the year-ago quarter, about 73 percent growth. Board also re-appointed Mr. Dipen Maheshwari as Managing Director for 3 years from April 1, 2027, subject to shareholder approval at the 32nd AGM scheduled on September 17, 2026.
Strong Q1 EPS growth of about 73 percent year-on-year signals improving profitability. MD re-appointment provides leadership continuity. Mildly positive for shareholders.